IMVT (IMVT) Stock Price & Analysis
IMVT (IMVT) rose 0.00% to USD 39.41 as of July 25, 2026 at 03:46 UTC, according to Nexqual real-time market data.
IMVT last closed at USD 39.41; the session ranged USD 38.7–39.87 on volume of 703,215 shares. Market capitalization is —, with a 52-week range of USD 14.32–41.23 (NMS). Source: Nexqual, July 25, 2026 at 03:46 UTC.
Key Statistics (as of July 25, 2026 at 03:46 UTC)
| Price | USD 39.41 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 39.41 |
| Open | USD 39.41 |
| Day Range | USD 38.7 – 39.87 |
| 52-Week Range | USD 14.32 – 41.23 |
| Volume | 703,215 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IMVT)
Nexqual's technical model rates IMVT "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:46 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.59 (neutral) |
| vs SMA50 | Above (USD 35.42) |
| MACD | 1.15 (positive) |
From IMVT's Latest SEC 10-K Filing (filed 2026-05-20)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | USD 35.01 | ▲ 0.29% |
| PCVX | Vaxcyte, Inc. | USD 54.66 | ▼ 2.39% |
| IDYA | IDEAYA Biosciences, Inc. | USD 35.4 | ▲ 1.14% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
| BBIO | BridgeBio Pharma, Inc. | USD 84.02 | ▲ 1.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:46 UTC. This page is informational and not investment advice.